Global Artificial Intelligence (AI) in Drug Discovery Market to Reach $12 Billion by 2030
The global market for Artificial Intelligence (AI) in Drug Discovery estimated at US$2.3 Billion in the year 2023, is expected to reach US$12 Billion by 2030, growing at a CAGR of 26.3% over the analysis period 2023-2030. AI in Oncology Drug Discovery, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the AI in Neurodegenerative Diseases Drug Discovery segment is estimated at 24% CAGR for the next 7-year period.
The U.S. Market is Estimated at $751.4 Million, While China is Forecast to Grow at 25.7% CAGR
The Artificial Intelligence (AI) in Drug Discovery market in the U.S. is estimated at US$751.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 25.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 23% and 22.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 18.5% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook